The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2020 | CAR-T and cellular therapy at ASH 2020
Noopur Raje, MD, Massachusetts General Hospital, Boston, MA discusses what updates to expect at ASH 2020 in the field of CAR-T and cellular therapy. This includes data on second generation CAR-T cell therapy, with more products with manufacturing differences. Trials of allogeneic CARs will also be presented for the first time. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.
